Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer

NAD salvage is one of the pathways used to generate NAD in mammals. Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in this pathway, uses nicotinamide (NAM) to generate nicotinamide mononucleotide (NMN). NMN is one of the main precursors of NAD synthesis in cells. Our previo...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Espindola-Netto, Jair Machado, Chini, Claudia C.S., Tarragó, Mariana, Wang, Enfeng, Dutta, Shamit, Pal, Krishnendu, Mukhopadhyay, Debabrata, Sola-Penna, Mauro, Chini, Eduardo N.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689593/
https://ncbi.nlm.nih.gov/pubmed/29156703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18841
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料